July 11, 2025 a 03:43 pm
DVA: Fundamental Ratio Analysis - DaVita Inc.
DaVita Inc., a leader in kidney dialysis services, offers a comprehensive range of healthcare services. With a strong presence both in the US and internationally, the company continues to exhibit steady growth. However, challenges in the healthcare industry could impact future prospects.
Fundamental Rating
DaVita Inc. presents a mixed fundamental rating with some room for improvement in financial metrics like ROE and Debt to Equity.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 1 |
Historical Rating
The following table compares the current and previous fundamental scores:
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-10 | 3 | 5 | 1 | 4 | 1 | 3 | 1 |
| Previous | 0 | 5 | 1 | 4 | 1 | 3 | 1 |
Analyst Price Targets
The consensus suggests a stable price target for DaVita Inc. with no major shifts expected in the near term.
| High | Low | Median | Consensus |
|---|---|---|---|
| 184 | 184 | 184 | 184 |
Analyst Sentiment
Most analysts hold a neutral stance on DaVita Inc., reflected by the majority 'Hold' recommendations.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 8 | |
| Hold | 14 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
DaVita Inc.'s comprehensive service offering and strong market presence are key advantages in the healthcare sector. However, current financial metrics suggest certain weaknesses, such as low ROE and high debt levels. Analyst sentiment remains largely neutral, indicating steady but unspectacular performance expectations. Potential investors should weigh these factors carefully while considering the overall market environment.